Thyroid hormone use in patients with breast cancer. Absence of an association
Wallace, R.B.; Sherman, B.M.; Bean, J.A.; Leeper, J.
JAMA 239(10): 958
1978
ISSN/ISBN: 0098-7484 PMID: 628042 Document Number: 138841
Document emailed within 1 workday
Related Documents
Gorman, C.A.; Becker, D.V.; Greenspan, F.S.; Levy, R.P.; Oppenheimer, J.H.; Rivlin, R.S.; Robbins, J.; VanderLaan, W.P. 1977: American thyroid association statement: breast cancer and thyroid hormone therapy Annals of Internal Medicine 86(4): 502-503Brian, D.D.; Tilley, B.C.; Labarthe, D.R.; O'Fallon, W.M.; Noller, K.L.; Kurland, L.T. 1980: Breast cancer in DES-exposed mothers: absence of association Mayo Clinic Proceedings 55(2): 89-93
Balaton, A.L.; Coindre, J.M.; Collin, F.; Ettore, F.; Fiche, M.; Jacquemier, J.; Le Doussal, V.; Mandard, A.M.; Mathieu, M.C.; Migeon, C.; Simony-Lafontaine, J.; Treilleux, I.; Verriele, V.; Vilain, M.O.; Zafrani, B. 1996: Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast cancer. Study Group on Hormone Receptors using Immunohistochemistry FNCLCC/AFAQAP. National Federation of Centres to Combat Cancer/French Association for Quality Assurance in Pathology Annales de Pathologie 16(2): 144-148
Nozaki, H.; Funahashi, H.; Sato, Y.; Imai, T.; Oike, E.; Kato, M.; Takagi, H. 1991: Study of hormone replacement therapy following total thyroidectomy in thyroid cancer--with special reference to the analysis of thyroid hormone peripheral effects, using indirect calorimetry Nihon Geka Gakkai Zasshi 92(12): 1700-1707
Sinaei, F.; Zendehdel, K.; Adili, M.; Ardestani, A.; Montazeri, A.; Mohagheghi, M.Ali. 2017: Association Between Breast Reconstruction Surgery and Quality of Life in Iranian Breast Cancer Patients Acta Medica Iranica 55(1): 35-41
Thomas-Morvan, C.; Nataf, B.; Tubiana, M. 1977: In vivo and organ culture studies of thyroid proteins and hormone synthesis in human thyroid cancer tissues Annales de Radiologie 20(8): 739-742
Yokoe, T.; Iino, Y.; Takei, H.; Horiguchi, J.; Koibuchi, Y.; Maemura, M.; Ohwada, S.; Morishita, Y. 1997: Changes of cytokines and thyroid function in patients with recurrent breast cancer Anticancer Research 17(1b): 695-699
Lundin, A.C.; Söderkvist, P.; Eriksson, B.; Bergman-Jungeström, M.; Wingren, S. 1999: Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group Cancer Research 59(10): 2332-2334
Fu, H.; Ma, C.; Tang, L.; Wu, F.; Liu, B.; Wang, H. 2015: Recombinant human thyrotropin versus thyroid hormone withdrawal in radioiodine remnant ablation for differentiated thyroid cancer: a meta-analysis Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 59(1): 121-128
Ghinea, E.; Dumitriu, L.; Stefanovici, G.; Pop, A.; Damian, A.; Handoca, A.; Stanciu, R. 1988: Protein content and thyroid hormone release in vitro by differentiated thyroid cancer cells in the presence of estradiol, dehydroepiandrosterone, polypeptidic hormones and pesticides Endocrinologie 26(3): 165-171
Semiglazov, V.F.; Moiseenko, V.M.; Ivanova, O.A. 1986: Prospective randomized study of the efficacy of adjuvant hormone therapy in patients with breast cancer Voprosy Onkologii 32(8): 31-34
Spicer, D.; Pike, M.; Lobo, R.; Paganini-Hill, A.; Richardson, J.; Dworsky, R.; Weaver, F. 1990: Gonadotropin hormone releasing hormone agonists [GnRHA] and prevention of familial breast cancer Progress in Clinical and Biological Research 339: 193-199
Bhatkar, S.V.; Rajan, M.G.R.; Velumani, A.; Samuel, A.M. 2004: Thyroid hormone binding protein abnormalities in patients referred for thyroid disorders Indian Journal of Medical Research 120(3): 160-165
Symons, R.G.; Murphy, L.J.; Cai, W.Y. 1987: Effect of thyroid hormone dosage on thyroid function tests in T4-replaced hypothyroid patients Chinese Medical Journal 100(3): 211-215
Nedvídková, J.; Felt, V. 1976: Response of the thyrotropic hormone after oral administration of thyrotropin releasing hormone in patients with disorders of the thyroid gland Vnitrni Lekarstvi 22(3): 278-282
Tirosh, E.; Taub, Y.; Scher, A.; Jaffe, M.; Hochberg, Z. 1989: Short-term efficacy of thyroid hormone supplementation for patients with Down syndrome and low-borderline thyroid function American Journal of Mental Retardation: Ajmr 93(6): 652-656
Aryandono, T.; Harijadi; Ghozali, A. 2000: Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 600-606
Uhlenbruck, G.; VAN Leendert, R.; Schneider, B.; Beuth, J. 2010: Reduced side-effects of adjuvant hormone therapy in breast cancer patients by complementary medicine In Vivo 24(5): 799-802
Anjum, S.; Khan, S.; Baig, S.M.; Khanum, A.; Haider, M.Z.; Qazi, M.H. 1991: Effect of chemotherapy on circulating steroid hormone levels in postoperative premenopausal breast cancer patients JPMA. Journal of the Pakistan Medical Association 41(12): 296-298
Sunthornthepvarakul, T.; Jaruratanasirikul, S.; Likitmaskul, S.; Angsusingha, K.; Ngowngarmratana, S. 2000: An identical neo-mutation in the thyroid hormone receptor beta gene (A317T) in 2 unrelated Thai families with resistance to thyroid hormone Journal of the Medical Association of Thailand 83(2): 139-145